002: The Biopharma Exit Strategy With Dr. Francois Nader
Business Of Biotech
00:00
The Challenges of Building a Plus Team
Investor community wants to hear about people because people make good products. With no exception, every investor I talk to believe in people first. It is usually more challenging to build a plus team. You have the best product in the world in the hands of people who don't know how to manage it will become a failure.
Play episode from 21:29
Transcript
